NASDAQ: CRNXCrinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?
Insider buying vs selling
Have Crinetics Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dana Pizzuti | Chief Med and Dev Officer | 2025-10-01 | 5,000 | $41.81 | $209.05kSell |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-10-01 | 5,000 | $16.89 | $84.45kBuy |
| Matthew K. Fust | Director | 2025-09-26 | 10,000 | $1.91 | $19.10kBuy |
| Richard Scott Struthers | President CEO | 2025-09-26 | 4,000 | $45.00 | $180.00kSell |
| Matthew K. Fust | Director | 2025-09-26 | 16,000 | $44.75 | $716.00kSell |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-09-02 | 5,000 | $32.10 | $160.50kSell |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-09-02 | 5,000 | $16.89 | $84.45kBuy |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-08-22 | 30,000 | $30.43 | $912.90kSell |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-08-22 | 30,000 | $16.89 | $506.70kBuy |
| Dana Pizzuti | Chief Med and Dev Officer | 2025-08-20 | 6,492 | $29.18 | $189.44kSell |
CRNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRNX insiders and whales buy or sell their stock.
CRNX Shareholders
What type of owners hold Crinetics Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 15.08% | 14,125,999 | $622.25M | Institution |
| Vanguard Group Inc | 9.88% | 9,256,132 | $407.73M | Institution |
| Perceptive Advisors LLC | 8.44% | 7,908,985 | $348.39M | Insider |
| Blackrock Inc | 7.92% | 7,418,715 | $326.79M | Institution |
| Driehaus Capital Management LLC | 6.83% | 6,400,025 | $281.92M | Institution |
| Wellington Management Group LLP | 6.20% | 5,807,308 | $255.81M | Institution |
| Price T Rowe Associates Inc | 5.97% | 5,590,504 | $246.26M | Institution |
| Farallon Capital Management LLC | 4.96% | 4,646,098 | $204.66M | Institution |
| Ecor1 Capital LLC | 4.58% | 4,288,120 | $188.89M | Institution |
| Janus Henderson Group PLC | 3.64% | 3,410,320 | $150.22M | Institution |
CRNX vs Biotech Stocks
Crinetics Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.